Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of intravenous favipiravir plus oseltamivir for hospitalized older adults with influenza
jRCT2031240586Phase 2Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of favipiravir, oseltamivir in influenza, sponsored by Japan Agency for Medical Research and Development. Started Jan 2025; status: recruiting.
02
Drugs
favipiraviroseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2031240586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240586.